TECH
Bio-Techne Corp
72.40$
+0.1%
vs. previous close
Closing price · As of: Sep 17, 2026
Statements
Income Statement
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | +10.3% | +12.8% | +14.2% | +11.0% | +3.5% | +26.0% | +18.7% | +2.8% | +2.0% | +5.2% | -0.4% | |
| – | +12.0% | +16.1% | +11.9% | +14.1% | +6.2% | +16.7% | +17.1% | +5.1% | +6.1% | +10.3% | -3.1% | |
| – | +9.6% | +11.3% | +15.4% | +9.6% | +2.0% | +31.0% | +19.5% | +1.8% | 0.0% | +2.7% | +1.1% | |
| – | +10.6% | +18.4% | +3.4% | +12.8% | +4.5% | +8.3% | +23.4% | +6.1% | +4.5% | +2.9% | -4.8% | |
| – | +18.0% | +8.8% | +56.9% | -1.6% | +1.7% | +20.4% | +16.9% | +4.0% | +11.6% | +5.5% | +9.0% | |
| – | +16.1% | +35.8% | +17.1% | +10.4% | -0.3% | +21.4% | +16.3% | +2.4% | +19.6% | +22.2% | -20.5% | |
| – | +2.4% | -19.1% | +11.8% | -7.8% | +25.4% | +50.7% | +25.0% | +0.8% | -30.9% | -50.5% | +146.3% | |
| – | +13.2% | +321.1% | +38.4% | +113.0% | -11.6% | -27.3% | -18.9% | -0.8% | +40.3% | -45.9% | -36.5% | |
| – | -4.3% | -23.3% | +11.3% | -11.1% | +146.8% | -46.4% | +103.4% | +12.4% | -45.2% | -47.0% | +144.4% | |
| – | -7.4% | -16.6% | -98.3% | +2,548.3% | +195.9% | -81.8% | +345.7% | +39.0% | -67.0% | +42.5% | +134.7% | |
| – | -3.0% | -26.0% | +62.2% | -23.4% | +138.7% | -38.8% | +93.8% | +4.9% | -41.1% | -56.3% | +147.8% | |
| – | +4.9% | -6.0% | +10.4% | +5.6% | +78.6% | -34.0% | +65.6% | +10.5% | -31.5% | -30.7% | +58.4% |
Data as of: September 17, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.